Glaukos Corporation (GKOS)
NYSE
Real-time Data
01:30 PM
Day's Range
179.2952 wk Range
73.16Overview - GKOS - Glaukos Corporation
Key Statistics
Valuation
Enterprise Value
10.76B
P/E (Trailing)
‪-55.40‬
P/E (Forward)
‪368.11‬
PEG Ratio
‪6.27‬
Price / Sales (TTM)
‪17.86‬
Price / Book
‪16.01‬
EV / EBITDA
‪-290.79‬
Profitability
Gross Margin
‪81.67%‬
Profit Margin
‪-30.68%‬
Operating Margin
‪-8.49%‬
Return on Assets
‪-5.17%‬
Return on Equity
‪-25.98%‬
Ownership
Shares Outstanding
58.85M
Float
56.81M
Short % of Shares Outstanding
‪7.44%‬
Held by Insiders
‪3.60%‬
Held by Institutions
‪105.45%‬
Price stats
Beta
‪0.76‬
50-Day Avg
‪158.09‬
200-Day Avg
‪125.21‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
14 analysts
Average price target
‪$ 197.15‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GKOS - Glaukos Corporation
Peers - GKOS - Glaukos Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
- GKOSNYSEGlaukos Corporation10.95BMarket Cap+48.36%52-week change-55.40P/E (Trailing)‪-30.68%‬Profit Margin
- CVXNYSEChevron Corporation398.38BMarket Cap+21.55%52-week change19.34P/E (Trailing)‪9.83%‬Profit Margin
- ABTNYSEAbbott Laboratories201.88BMarket Cap-13.28%52-week change37.75P/E (Trailing)‪11.64%‬Profit Margin
- SYKNYSEStryker Corporation126.36BMarket Cap-19.25%52-week change34.14P/E (Trailing)‪14.43%‬Profit Margin
- MDTNYSEMedtronic plc118.91BMarket Cap+0.93%52-week change25.03P/E (Trailing)‪13.20%‬Profit Margin
- ICENYSEIntercontinental Exchange, Inc.90.52BMarket Cap-11.10%52-week change22.71P/E (Trailing)‪38.24%‬Profit Margin
- BSXNYSEBoston Scientific Corporation71.02BMarket Cap-114.47%52-week change20.39P/E (Trailing)‪17.49%‬Profit Margin
Profile Summary - GKOS - Glaukos Corporation
About
Glaukos Corporation is a medical technology company dedicated to the development and commercialization of innovative products for the treatment of glaucoma, corneal disorders, and retinal diseases. Its primary function is to address the substantial unmet medical needs present in ophthalmic healthcare. Glaukos is…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
